Mechanism of inhibition of human cytomegalovirus replication by oxetanocin G
- 30 April 1991
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 176 (2), 805-812
- https://doi.org/10.1016/s0006-291x(05)80257-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Inhibition of infectivity of human immunodeficiency virus by a novel nucleoside, oxetanocin, and related compoundsAntimicrobial Agents and Chemotherapy, 1989
- An in vitro system for screening anti-hepatitis b virus drugsVirology, 1989
- Efficacy of oxetanocin G against herpes simplex virus type 2 and murine cytomegalovirus infections in mice.The Journal of Antibiotics, 1989
- Selective inhibition of human cytomegalovirus replication by a novel nucleoside, oxetanocin GAntimicrobial Agents and Chemotherapy, 1988
- Inhibition of infectivity of human immunodeficiency virus by oxetanocin.The Journal of Antibiotics, 1987
- Derivatives of oxetanocin: Oxetanocins H, X and G, and 2-aminooxetanocin A.The Journal of Antibiotics, 1987
- Oxetanocin, a novel nucleoside from bacteria.The Journal of Antibiotics, 1986
- Characterization of an aphidicolin-resistant mutant of herpes simplex virus type 2 which induces an altered viral DNA polymeraseVirology, 1984
- Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitroAntimicrobial Agents and Chemotherapy, 1983
- Characterization of human cytomegalovirus-induced DNA polymerase and the associated 3′-to−5′, exonucleaseVirology, 1983